Common Contracts
3 similar Registration Rights Agreement contracts by Dianthus Therapeutics, Inc. /DE/, Palatin Technologies Inc, Reviva Pharmaceuticals Holdings, Inc.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 12th, 2023 • Dianthus Therapeutics, Inc. /DE/ • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of September 11, 2023, among Dianthus Therapeutics, Inc., a Delaware corporation, Magenta Therapeutics, Inc. (“Magenta”), a Delaware corporation, and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 18th, 2020 • Reviva Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 14, 2020, by and between Reviva Pharmaceuticals Holdings, Inc., a Delaware corporation (formerly Tenzing Acquisition Corp., a company incorporated in the British Virgin Islands (the “Predecessor”)) (together with the Predecessor and its successors, the “Company”), and [__________] (“Holder”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 7th, 2015 • Palatin Technologies Inc • Pharmaceutical preparations
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and certain purchasers named therein (the “Purchase Agreement”) and the Series G 2015 Documentation.
